OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Structure-Based Drug Design of Novel Piperazine Containing Hydrazone Derivatives as Potent Alzheimer Inhibitors: Molecular Docking and Drug Kinetics Evaluation
Abduljelil Ajala, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Brain Disorders (2022) Vol. 7, pp. 100041-100041
Open Access | Times Cited: 10
Abduljelil Ajala, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Brain Disorders (2022) Vol. 7, pp. 100041-100041
Open Access | Times Cited: 10
Showing 10 citing articles:
Therapeutic exploration potential of adenosine receptor antagonists through pharmacophore ligand-based modelling and pharmacokinetics studies against Parkinson disease
Abduljelil Ajala, Otaru Habiba Asipita, Abatyough Terungwa Michael, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
Abduljelil Ajala, Otaru Habiba Asipita, Abatyough Terungwa Michael, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
Virtual screening and pharmacokinetics analysis of inhibitors against tuberculosis: Structure and ligand-based approach
Stephen Eyije Abechi, Abatyough Terungwa Michael, Abduljelil Ajala, et al.
Scientific African (2024) Vol. 23, pp. e02085-e02085
Open Access | Times Cited: 3
Stephen Eyije Abechi, Abatyough Terungwa Michael, Abduljelil Ajala, et al.
Scientific African (2024) Vol. 23, pp. e02085-e02085
Open Access | Times Cited: 3
Synthesis, crystal structure, antioxidant activity and molecular docking studies of 2-(1-(3-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)ethyl)malononitrile
Rachid Bouzammit, Imane Lakkab, Mohamed El fadili, et al.
Journal of Molecular Structure (2024) Vol. 1312, pp. 138582-138582
Closed Access | Times Cited: 3
Rachid Bouzammit, Imane Lakkab, Mohamed El fadili, et al.
Journal of Molecular Structure (2024) Vol. 1312, pp. 138582-138582
Closed Access | Times Cited: 3
QSAR, simulation techniques, and ADMET/pharmacokinetics assessment of a set of compounds that target MAO-B as anti-Alzheimer agent
Abduljelil Ajala, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Future Journal of Pharmaceutical Sciences (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Abduljelil Ajala, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Future Journal of Pharmaceutical Sciences (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Synthesis of novel 1,2,3-triazole-tethered N-acyl hydrazones as a new class of carbonic anhydrase II inhibitors: In vitro and in silico potentials
Noor Fatima, Aamer Saeed, Saeed Ullah, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107822-107822
Closed Access | Times Cited: 2
Noor Fatima, Aamer Saeed, Saeed Ullah, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107822-107822
Closed Access | Times Cited: 2
Drug Candidates for the Treatment of Alzheimer’s Disease: New Findings from 2021 and 2022
Sujatha L. Motebennur, B. P. Nandeshwarappa, Manjunatha S. Katagi
Drugs and Drug Candidates (2023) Vol. 2, Iss. 3, pp. 571-590
Open Access | Times Cited: 5
Sujatha L. Motebennur, B. P. Nandeshwarappa, Manjunatha S. Katagi
Drugs and Drug Candidates (2023) Vol. 2, Iss. 3, pp. 571-590
Open Access | Times Cited: 5
Natural product inhibitors as potential drug candidates against Alzheimer's disease: Structural-based drug design, molecular docking, molecular dynamic simulation experiments, and ADMET predictions
Abduljelil Ajala, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Journal of the Indian Chemical Society (2023) Vol. 100, Iss. 5, pp. 100977-100977
Closed Access | Times Cited: 4
Abduljelil Ajala, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Journal of the Indian Chemical Society (2023) Vol. 100, Iss. 5, pp. 100977-100977
Closed Access | Times Cited: 4
TD-DFT calculations, dipole moments, and solvatochromic properties of 2-aminochromone-3-carboxaldehyde and its hydrazone derivatives
Omima M.I. Adly, Ali Taha, Shery A. Fahmy, et al.
RSC Advances (2023) Vol. 13, Iss. 38, pp. 26587-26603
Open Access | Times Cited: 2
Omima M.I. Adly, Ali Taha, Shery A. Fahmy, et al.
RSC Advances (2023) Vol. 13, Iss. 38, pp. 26587-26603
Open Access | Times Cited: 2
In silico and in vitro assessment of the anti-β-amyloid aggregation and anti-cholinesterase activities of Ptaeroxylon obliquum and Bauhinia bowkeri extracts
Michael C. Ojo, Rebamang A. Mosa, Foluso Oluwagbemiga Osunsanmi, et al.
Electronic Journal of Biotechnology (2023) Vol. 68, pp. 67-80
Open Access | Times Cited: 1
Michael C. Ojo, Rebamang A. Mosa, Foluso Oluwagbemiga Osunsanmi, et al.
Electronic Journal of Biotechnology (2023) Vol. 68, pp. 67-80
Open Access | Times Cited: 1
Synthesis of Piperazine-containing Derivatives and their Antimicrobial, Antimycobacterial, Antimalarial and Antioxidant Activities
Navin B. Patel, Pratik N. Maisuria, Akash V. Gujarati, et al.
Current Bioactive Compounds (2023) Vol. 20, Iss. 6
Closed Access
Navin B. Patel, Pratik N. Maisuria, Akash V. Gujarati, et al.
Current Bioactive Compounds (2023) Vol. 20, Iss. 6
Closed Access
